Chaotic Printing of Non-Filamentous Scaffolds for Tissue Perfusion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current tissue engineering strategies face challenges in replicating the hierarchical organization of microvasculature to achieve homogeneous blood perfusion in large-scale engineered tissues and organs, limiting their clinical viability due to the inability to establish long-term blood perfusion from native arteries to all regions of the construct.

Innovation Solution

The development of non-filamentous scaffolds through chaotic printing, using a Kenics static mixer and bioink compositions, to create lamellar structures that mimic the branching networks of microvasculature, allowing for the extrusion of microstructured precursors that are cured to form scaffolds suitable for cell or tissue culture.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional filamentous scaffolds are used, then the scaffold structure is simple to manufacture, but the blood perfusion homogeneity deteriorates due to inability to replicate hierarchical microvasculature

Engineering Contradiction:
Improvemicrovasculature structure precisionVSAvoidscaffold structure complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The scaffold is segmented into hierarchical levels mimicking the natural microvasculature structure, with macro-scale arterial structures branching into micro-scale capillary networks. This segmentation enables precise replication of blood flow distribution patterns while maintaining manufacturing feasibility through modular fabrication approaches

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the scaffold are assigned different structural qualities corresponding to specific vascular functions. Arterial regions have thicker walls and larger lumens for high-flow transport, while capillary regions have thinner walls and smaller diameters for exchange functions, creating locally optimized structures that improve overall perfusion homogeneity

Inventive Principle:
Principle #3Local quality

2Volume of moving object

If large-scale tissue constructs are created, then the tissue size increases for clinical relevance, but the oxygen diffusion distance exceeds 200 microns without direct capillary contact

Engineering Contradiction:
Improvetissue construct volumeVSAvoidoxygen delivery reliability
Core Design Contradiction:
Volume of moving objectVSReliability

Solution Approach 1:

The scaffold employs a nested hierarchical structure where capillary networks are embedded within tissue constructs, which are themselves organized around arterial structures. This nested arrangement ensures that every region of the large-scale construct remains within 200 microns of a capillary, maintaining oxygen delivery reliability while achieving clinically relevant tissue volumes

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The vascular network is extended into the third dimension throughout the tissue construct volume, creating a volumetric distribution of capillaries rather than a planar arrangement. This 3D vascular architecture ensures comprehensive oxygen delivery to all regions of large-scale constructs, eliminating diffusion distance limitations

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Stability of the object's composition

If hierarchical microvasculature networks are replicated, then the blood perfusion homogeneity improves, but the manufacturing process complexity increases

Engineering Contradiction:
Improveblood supply homogeneityVSAvoidfabrication process ease
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The hierarchical microvasculature structure is pre-formed within the scaffold using controlled deposition techniques before tissue implantation. Arterial and capillary networks are established in advance with precise spatial positioning, eliminating the need for post-implantation vascularization and ensuring immediate homogeneous blood perfusion upon implantation

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

Traditional mechanical assembly methods for creating vascular networks are replaced with advanced fabrication techniques such as stereolithography and extrusion-based bioprinting. These methods enable precise deposition of vascular structures layer-by-layer, achieving complex hierarchical architectures with high manufacturing precision while reducing manual intervention

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the production of scaffolds with thin, lamellar structures that facilitate homogeneous blood supply, promoting cell interaction and organ-level function, thereby addressing the perfusion limitations in large-scale tissue engineering.

Implementation Method 1

chaotic printing the first printing composition and the second printing composition to generate a microstructured precursor comprising a plurality of lamellar structures

Methodology Applied
Scientific EffectChaotic mixing: Turbulence

Implementation Method 2

extruding the microstructured precursor through a nozzle to produce a non-filamentous microstructured precursor

Methodology Applied
Scientific EffectExtrusion: Extrusion

Implementation Method 3

curing the non-filamentous microstructured precursor to provide the non-filamentous scaffold for cell or tissue culture

Methodology Applied
Scientific EffectCuring: Photopolymerisation

Data Source

PatentUS20250296278A1Chaotic printing for the production of non-filamentous architectures
Publication Date: 2025.09.25 OHIO STATE INNOVATION FOUND
  • US20250296278A1 patent drawing
  • US20250296278A1 patent drawing
  • US20250296278A1 patent drawing

AI summary

Disclosed are methods for preparing non-filamentous scaffolds (e.g., sheets) for cell or tissue culture. These methods can comprise providing at least a first printing composition (e.g., a bioink) and a second printing composition (e.g., a bioink or a fugitive ink); chaotic printing the first printing composition and the second printing composition to generate a microstructured precursor comprising a plurality of lamellar structures formed from the first printing composition and the second printing composition; extruding the microstructured precursor through a nozzle (e.g., a fan-shaped nozzle, a curved fan-shaped nozzle, or an annular nozzle) to produce a non-filamentous microstructured precursor; and curing the non-filamentous microstructured precursor to provide the non-filamentous scaffold for cell or tissue culture.